patent/NO-333904-B1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-333904-B1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C04B35-632 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	2006-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04fbeb5209c87649b889e1020c794317 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca522bcb5779e48c5bf8ccf0e0ab01ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3592b95126b8ed4d6c3a8b184e4c225
publicationDate	2013-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	NO-333904-B1
titleOfInvention	Quinazoline derivatives, method of manufacture thereof and intermediates, pharmaceutical preparations comprising such, such compounds for use as medicaments and the use thereof for the manufacture of medicaments for the treatment of disease
abstract	The invention relates to quinazoline derivatives of formula I: wherein each of R 1, X 1, R 2, R 3, R 5, n and m has any of the meanings defined in the specification; methods for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent for the prevention or treatment of tumors sensitive to inhibition of EGF and erbB receptor tyrosine kinases.
priorityDate	2003-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490761

Total number of triples: 26.